Early reports on CanSino’s Covid vaccine say it’s safe, generates an immune response

The Print | May 23, 2020 at 7:35 AM
  • An experimental Covid-19 vaccine developed by China’s CanSino Biologics, one of the front-runners in the global race to come up with a shot to help end the pandemic, was safe and generated an immune response in an early study in humans.
  • Mobilizing huge resources, China has five potential shots in human testing, while the Trump administration in the U.S. has responded with an effort to get a vaccine across the line called Operation Warp Speed.
  • The Oxford researchers have countered that the comparison is inapt for studies carried out with different types of vaccines given in varying doses.